These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25710579)

  • 1. Prognostic Significance of CD44v6, CD133, CD166, and ALDH1 Expression in Small Intestinal Adenocarcinoma.
    Eom DW; Hong SM; Kim G; Bae YK; Jang KT; Yu E
    Appl Immunohistochem Mol Morphol; 2015; 23(10):682-8. PubMed ID: 25710579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
    Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance.
    Okudela K; Woo T; Mitsui H; Tajiri M; Masuda M; Ohashi K
    Pathol Int; 2012 Dec; 62(12):792-801. PubMed ID: 23252868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
    Kapucuoğlu N; Bozkurt KK; Başpınar Ş; Koçer M; Eroğlu HE; Akdeniz R; Akçil M
    Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors.
    Lan J; Huang B; Liu R; Ju X; Zhou Y; Jiang J; Liang W; Shen Y; Li F; Pang L
    Int J Clin Exp Pathol; 2015; 8(10):12621-33. PubMed ID: 26722452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
    Lugli A; Iezzi G; Hostettler I; Muraro MG; Mele V; Tornillo L; Carafa V; Spagnoli G; Terracciano L; Zlobec I
    Br J Cancer; 2010 Jul; 103(3):382-90. PubMed ID: 20606680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater.
    Piscuoglio S; Lehmann FS; Zlobec I; Tornillo L; Dietmaier W; Hartmann A; Wünsch PH; Sessa F; Rümmele P; Baumhoer D; Terracciano LM
    J Clin Pathol; 2012 Feb; 65(2):140-5. PubMed ID: 22130902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer.
    Galizia G; Gemei M; Del Vecchio L; Zamboli A; Di Noto R; Mirabelli P; Salvatore F; Castellano P; Orditura M; De Vita F; Pinto M; Pignatelli C; Lieto E
    Arch Surg; 2012 Jan; 147(1):18-24. PubMed ID: 22250106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.
    Park JJ; Kwon JH; Oh SH; Choi J; Moon CM; Ahn JB; Hong SP; Cheon JH; Kim TI; Kim H; Kim WH
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E1-10. PubMed ID: 23065858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
    Wakamatsu Y; Sakamoto N; Oo HZ; Naito Y; Uraoka N; Anami K; Sentani K; Oue N; Yasui W
    Pathol Int; 2012 Feb; 62(2):112-9. PubMed ID: 22243781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes.
    Roudi R; Korourian A; Shariftabrizi A; Madjd Z
    Cancer Invest; 2015; 33(7):294-302. PubMed ID: 26046383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer.
    Horst D; Kriegl L; Engel J; Kirchner T; Jung A
    Cancer Invest; 2009 Oct; 27(8):844-50. PubMed ID: 19626493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy.
    Deng Y; Zhou J; Fang L; Cai Y; Ke J; Xie X; Huang Y; Huang M; Wang J
    Br J Cancer; 2014 Jan; 110(2):430-4. PubMed ID: 24327017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-expression of CD133, CD44v6 and human tissue factor is associated with metastasis and poor prognosis in pancreatic carcinoma.
    Chen K; Li Z; Jiang P; Zhang X; Zhang Y; Jiang Y; He Y; Li X
    Oncol Rep; 2014 Aug; 32(2):755-63. PubMed ID: 24920554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD133/CD166/Ki-67 triple immunofluorescence assessment for putative cancer stem cells in colon carcinoma.
    Mărgaritescu C; Pirici D; Cherciu I; Bărbălan A; Cârtână T; Săftoiu A
    J Gastrointestin Liver Dis; 2014 Jun; 23(2):161-70. PubMed ID: 24949608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia.
    Liu W; Wu L; Shen XM; Shi LJ; Zhang CP; Xu LQ; Zhou ZT
    Int J Cancer; 2013 Feb; 132(4):868-74. PubMed ID: 22782852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy.
    Mizukami T; Kamachi H; Mitsuhashi T; Tsuruga Y; Hatanaka Y; Kamiyama T; Matsuno Y; Taketomi A
    BMC Cancer; 2014 Sep; 14():687. PubMed ID: 25240521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putative stem cell markers in non-small-cell lung cancer: a clinicopathologic characterization.
    Sterlacci W; Savic S; Fiegl M; Obermann E; Tzankov A
    J Thorac Oncol; 2014 Jan; 9(1):41-9. PubMed ID: 24346092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133 is a useful surrogate marker for predicting chemosensitivity to neoadjuvant chemotherapy in breast cancer.
    Aomatsu N; Yashiro M; Kashiwagi S; Takashima T; Ishikawa T; Ohsawa M; Wakasa K; Hirakawa K
    PLoS One; 2012; 7(9):e45865. PubMed ID: 23049880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
    Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.